Personified
Pascal Soriot: "There are a lot of emotions on vaccines in EU. But it's complicated" - la Repubblica
Advancing data and artificial intelligence
AstraZeneca weighs spinning out COVID-19 products into separate company: Bloomberg | Fierce Pharma
Frontiers | Extension and Severity of Self-Reported Side Effects of Seven COVID-19 Vaccines in Mexican Population
Advancing data and artificial intelligence
Pakistan allows AstraZeneca shot for under 40s to help its expatriates | Reuters
AstraZeneca to acquire Neogene for $320 million
Keith Burns - Director of U.S. Tax Operations - AstraZeneca | LinkedIn
Vaccines | Free Full-Text | Prospective Evaluation of Side-Effects Following the First Dose of Oxford/AstraZeneca COVID-19 Vaccine among Healthcare Workers in Saudi Arabia
AstraZeneca plc | Access to Medicine Foundation
Vaccines | Free Full-Text | Report of Adverse Effects Following Population-Wide COVID-19 Vaccination: A Comparative Study between Six Different Vaccines in Baja-California, Mexico
/https://tf-cmsv2-smithsonianmag-media.s3.amazonaws.com/filer/14/29/14299510-33fb-45ec-b31f-740282f71b0c/march26_astrazeneca.jpg "Why U.S. Approval of the AstraZeneca Covid-19 Vaccine Is Taking So Long | Smart News| Smithsonian Magazine")
Why U.S. Approval of the AstraZeneca Covid-19 Vaccine Is Taking So Long | Smart News| Smithsonian Magazine
Rick R. Suarez
AstraZeneca faces $278M Imfinzi patent infringement lawsuit from co-developer Ono | Fierce Pharma
AstraZeneca's vaccine has 76 percent efficacy—slightly lower than the interim results announced Monday
National Geographic Traveler Latinoamérica - ¿Recibiste o recibirás la vacuna #AstraZeneca? Esto debes saber. 💉 | Facebook
AstraZeneca US and Health Equity: Today & Tomorrow
AstraZeneca US
New problems erode confidence in AstraZeneca's vaccine | Science
